Viewing Study NCT03869632


Ignite Creation Date: 2025-12-24 @ 9:44 PM
Ignite Modification Date: 2025-12-25 @ 7:24 PM
Study NCT ID: NCT03869632
Status: UNKNOWN
Last Update Posted: 2021-11-16
First Post: 2019-03-08
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: First in Human Dose Escalation Study of YL-13027 in Subjects With Advanced Stage Solid Tumors
Sponsor: Shanghai YingLi Pharmaceutical Co. Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module